References
- Chlebowski RT, Anderson GL, Gass M, . Estrogen plus progestin and breast cancer incidence and mortality in postmenopausal women. JAMA 2010;304:1684–92
- Stevenson JC, Hodis HN, Pickar JH, Lobo RA. Coronary heart disease and menopause management: the swinging pendulum of HRT. Atherosclerosis 2009;207:336–40
- Chlebowski RT, Hendrix SL, Langer RD, . Influence of estrogen plus progestin on breast cancer and mammography in healthy postmenopausal women. JAMA 2003;289:3243–53
- Rossouw JE, Prentice RL, Manson JE, . Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA 2007;297:1465–77
- Anderson GL, Chlebowski RT, Rossouw JE, . Prior hormone therapy and breast cancer risk in the Women's Health Initiative randomized trial of estrogen plus progestin. Maturitas 2006;55:103–15
- Chen WY, Hankinson SE, Schnitt SJ, Rosner BA, Holmes MD, Colditz GA. Association of hormone replacement therapy to estrogen and progesterone receptor status in invasive breast carcinoma. Cancer 2004;101:1490–500
- Li CI, Malone KE, Porter PL, . Relationship between menopausal hormone therapy and risk of ductal, lobular, and ductal-lobular breast carcinomas. Cancer Epidemiol Biomarkers Prev 2008;17:43–50
- Chlebowski RT, Kuller LH, Prentice RL, . Breast cancer after use of estrogen plus progestin in postmenopausal women. N Engl J Med 2009;360:573–87
- Schuetz F, Diel IJ, Pueschel M, . Reduced incidence of distant metastases and lower mortality in 1072 patients with breast cancer with a history of hormone replacement therapy. Am J Obstet Gynecol 2007;196:342 e1–9
- Sener SF, Winchester DJ, Winchester DP, . The effects of hormone replacement therapy on postmenopausal breast cancer biology and survival. Am J Surg 2009;197:403–7
- Salpeter SR, Walsh JM, Greyber E, . Mortality associated with hormone replacement therapy in younger and older women: a meta-analysis. J Gen Intern Med. 2004;19:791–804
- Salpeter SR, Cheng J, Thabane L, Buckley NS, Salpeter EE. Bayesian meta-analysis of hormone therapy and mortality in younger postmenopausal women. Am J Med 2009;122:1016–22
- Salpeter SR, Buckley NS, Liu H, Salpeter EE. The cost-effectiveness of hormone therapy in younger and older postmenopausal women. Am J Med 2009;122:42–52
- Stefanick ML, Anderson GL, Margolis KL, . Effects of conjugated equine estrogens on breast cancer and mammography screening in postmenopausal women with hysterectomy. JAMA 2006;295:1647–57
- LaCroix A, Chlebowski R, Manson JE, . Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011;305:1305–14
- Bluming AZ, Tavris C. Hormone replacement therapy: real concerns and false alarms. Cancer 2009;15:93–104
- Barrett-Connor E, Mosca L, Collins P, .; Raloxifene Use for The Heart (RUTH) Trial Investigators. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125–37
- Final report on the aspirin component of the ongoing Physicians’ Health Study. Steering Committee of the Physicians’ Health Study Research Group. N Engl J Med 1989;321:129–35
- Keech A, Simes RJ, Barter P, . FIELD study investigators. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial. Lancet 2005;366: 1849–61
- Graham DJ, Ouellet-Hellstrom R, MaCurdy TE, . Risk of acute myocardial infarction, stroke, heart failure, and death in elderly Medicare patients treated with rosiglitazone or pioglitazone. JAMA 2010;304:411–18
- Omenn GS, Goodman GE, Thornquist MD, . Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996;334:1150–5
- Bolland MJ, Avenell A, Baron JA, . Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2010;341:c3691
- Bolland MJ, Barber PA, Doughty RN, . Vascular events in healthy older women receiving calcium supplementation: randomised controlled trial. BMJ 2008;336:262–6